It's good. The company is a biomedical high-tech enterprise integrating the production and sales of R&D, in vitro diagnostic reagents, POCT instruments and biological raw materials, focusing on the production and sales of R&D and POCT reagents and instruments, and focusing on the development of biological raw material platform and product technical reserve. Now it has formed an integrated industrial chain layout from upstream core biological raw materials to diagnostic reagents and instruments, and it is one of the few China enterprises in the international market that can compete with multinational in vitro diagnostic giants.
Xu Min Bio-Fuyang Project is a project built by Xu Ansheng Bio-Fuyang with super-raised funds, with a total investment of 5.08 yuan.